Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TL-895 is an ATP-competitive, and highly selective irreversible inhibitor of Bruton’s Tyrosine Kinase(BTK). TL-895 showed good potency with an IC50 of 1.5 nM and a Ki of 11.9 nM.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,500 | |||
5 mg | 在庫あり | ¥ 22,500 | |||
10 mg | 在庫あり | ¥ 36,000 | |||
25 mg | 在庫あり | ¥ 73,000 | |||
50 mg | 在庫あり | ¥ 113,500 | |||
100 mg | 在庫あり | ¥ 166,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,500 |
説明 | TL-895 is an ATP-competitive, and highly selective irreversible inhibitor of Bruton’s Tyrosine Kinase(BTK). TL-895 showed good potency with an IC50 of 1.5 nM and a Ki of 11.9 nM. |
ターゲット&IC50 | BTK:1.5 nM, BTK:11.9 nM(Ki) |
分子量 | 447.5 |
分子式 | C25H26FN5O2 |
CAS No. | 1415823-49-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (558.66 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TL-895 1415823-49-2 Angiogenesis Tyrosine Kinase/Adaptors BTK anti-viral Inhibitor Bruton tyrosine kinase TL895 Myelofibrosis Solid Tumor Carcinoma TL 895 Acute Myeloid Leukemia Btk Cancer Sars-CoV2 COVID-19 inhibit inhibitor